Polaris BioPharma Consulting is Other Healthcare Services in United Kingdom that focus on site level business. Founded in 1999. They cover business area such as provider, clinical trial management consulting service, patient recruitment, retention, compliance, feasibility - protocol, country and site level, investigator, site training, clinical research, group interaction, related service.
1999
( 25 years old in 2024 )
Site Level
-
38A High Street
Middlesex
London HA6 1BN
England, United Kingdom
Private
providerclinical trial management consulting servicepatient recruitmentretentioncompliancefeasibility - protocol, country and site levelinvestigatorsite trainingclinical researchgroup interactionrelated service
* We use standard office opening hours in near Polaris BioPharma Consulting's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Polaris BioPharma Consulting is Other Healthcare Services business from United Kingdom that founded in 1999 (25 years old in 2024), Polaris BioPharma Consulting business is focusing on Site Level.
Polaris BioPharma Consulting headquarter office and corporate office address is located in 38A High Street Middlesex London HA6 1BN England, United Kingdom.
Polaris BioPharma Consulting was founded in United Kingdom.
In 2024, Polaris BioPharma Consulting is currently focus on site level sector.
Above is snippet of Google Trends for "site level" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Polaris BioPharma Consulting, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.